| PCMVX | VEVYX | PCMVX / VEVYX | |
| Total Expense Ratio | 1.07 | 0.66 | 162% |
| Annual Report Gross Expense Ratio | 1.09 | 0.66 | 165% |
| Fund Existence | 7 years | 13 years | - |
| Gain YTD | 7.484 | 4.348 | 172% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.34B | 16.1B | 15% |
| Annual Yield % from dividends | 1.02 | 1.02 | 100% |
| Returns for 1 year | -11.63 | -9.26 | 126% |
| Returns for 3 years | 1.28 | 1.31 | 98% |
| Returns for 5 years | 16.87 | 21.59 | 78% |
| Returns for 10 years | N/A | 58.93 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNAX | 78.05 | 0.75 | +0.97% |
| Janus Henderson Global Life Sciences A | |||
| RYAZX | 228.75 | 1.88 | +0.83% |
| Rydex S&P SmallCap 600 Pure Value H | |||
| SUSYX | 15.21 | 0.11 | +0.73% |
| SEI US Managed Volatility Y (SIMT) | |||
| RRGIX | 7.34 | 0.02 | +0.27% |
| DWS RREEF Global Real Estate Secc Inst | |||
| SXPAX | 56.30 | 0.12 | +0.21% |
| DWS S&P 500 Index A | |||